Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial

Trial Profile

Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 17 Feb 2017

At a glance

  • Drugs Alteplase (Primary) ; Heparin; Low molecular weight heparins; Warfarin
  • Indications Deep vein thrombosis; Peripheral vascular disorders
  • Focus Therapeutic Use
  • Acronyms PHLO
  • Most Recent Events

    • 28 Nov 2016 Planned End Date changed from 1 Jun 2021 to 1 Jun 2022.
    • 28 Nov 2016 Planned primary completion date changed from 1 Apr 2021 to 1 Apr 2022.
    • 28 Nov 2016 Planned initiation date changed from 1 Oct 2016 to 1 Jul 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top